Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study

Leukemia. 2021 Mar;35(3):924-928. doi: 10.1038/s41375-021-01154-z. Epub 2021 Feb 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Humans
  • Immunogenetics*
  • Neoplasm, Residual / genetics
  • Neoplasm, Residual / metabolism
  • Neoplasm, Residual / pathology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Prognosis
  • RNA-Seq / standards*
  • Transcriptome*
  • Whole Genome Sequencing / standards*

Substances

  • Biomarkers, Tumor